Enteropathy-associated T-cell lymphoma screening: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(8 intermediate revisions by 3 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Enteropathy-associated T-cell lymphoma}}
{{Enteropathy-associated T-cell lymphoma}}
{{CMG}}; {{AE}} {{AS}}
{{CMG}}; {{AE}}{{Nnasiri}} {{AS}}
==Overview==
==Overview==
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for enteropathy-associated T-cell lymphoma.
Enteropathy-associated T cell lymphoma is a very rare but aggressive disease, an extranodal form of [[non-Hodgkin lymphoma]] which has two subtypes, type I is associated with [[celiac disease]] and more common in the western population, type II is more common in Asian countries.
 
==Screening==
==Screening==
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for enteropathy-associated T-cell lymphoma.
*There is insufficient evidence to recommend routine screening for enteropathy-associated T-cell lymphoma.
 
==References==
==References==
{{reflist|2}}
{{reflist|2}}
Line 13: Line 15:
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Hematology]]
[[Category:Immunology]]
[[Category:Gastroenterology]]

Latest revision as of 15:13, 10 January 2019

Enteropathy-associated T-cell lymphoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Enteropathy-associated T-cell lymphoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Enteropathy-associated T-cell lymphoma screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Enteropathy-associated T-cell lymphoma screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Enteropathy-associated T-cell lymphoma screening

CDC on Enteropathy-associated T-cell lymphoma screening

Enteropathy-associated T-cell lymphoma screening in the news

Blogs on Enteropathy-associated T-cell lymphoma screening

Risk calculators and risk factors for Enteropathy-associated T-cell lymphoma screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nima Nasiri, M.D.[2] Sowminya Arikapudi, M.B,B.S. [3]

Overview

Enteropathy-associated T cell lymphoma is a very rare but aggressive disease, an extranodal form of non-Hodgkin lymphoma which has two subtypes, type I is associated with celiac disease and more common in the western population, type II is more common in Asian countries.

Screening

  • There is insufficient evidence to recommend routine screening for enteropathy-associated T-cell lymphoma.

References


Template:WikiDoc Sources